SCHEMBL805496

SCHEMBL805496

CCC1CCCN1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24667752 1.00
SCHEMBL17121688 0.93
SCHEMBL17121689 0.93
SCHEMBL8555817 0.93
SCHEMBL12738374 0.91 KMT2A (0.43)
SCHEMBL28173258 0.78 CYP1A2 (0.40)
SCHEMBL13589975 0.77
SCHEMBL13654461 0.77
SCHEMBL15076434 0.76 CASP3 (0.35)
SCHEMBL25828687 0.76 CASP3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3319963-B1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-01-08 EP disclosed
EP-2941238-B1 COSMETIC COMPOSITION OREAL (FR) 2019-10-16 EP disclosed
CN-105669664-B Benzothiazine -4- ketone compounds containing basic nitrogen heterocyclic fragments and preparation method thereof 浙江司太立制药股份有限公司 2019-05-10 CN disclosed
CN-109526219-A Benzsulfamide and its purposes as therapeutic agent 泽农医药公司 2019-03-26 CN disclosed
EP-2961751-B1 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS WOCKHARDT LTD (IN) 2018-03-21 EP disclosed
WO-2017007938-A1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-01-12 WO disclosed
CN-105669664-A Benzothiazine-4-ketone compounds containing basic nitrogen heterocyclic fragments and preparing methods of benzothiazine-4-ketone compounds 浙江司太立制药股份有限公司 2016-06-15 CN disclosed
US-20120070385-A1 Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives SPECTRUM PHARMACEUTICALS, INC. (US) 2012-03-22 US disclosed
US-8063233-B2 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives SPECTRUM PHARMACEUTICALS INC. (US) 2011-11-22 US disclosed
US-20110086866-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS, INC. (US) 2011-04-14 US disclosed
US-20090192319-A1 METHODS FOR TREATING COGNITIVE /ATTENTION DEFICIT DISORDERS USING TETRAHYDROINDOLONE ANALOGUES AND DERIVATIVES SPECTRUM PHARMACEUTICALS, INC. (US) 2009-07-30 US disclosed
US-7531670-B2 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives SPRECTRUM PHARMACEUTICALS, INC. (US) 2009-05-12 US disclosed
CN-100468092-C Colored composition for color filter and color filter TOYO INK MFG CO (JP) 2009-03-11 CN disclosed
CN-1330984-C Colored composition for color filter and color filter TOPPAN PRINTING CO LTD (JP) 2007-08-08 CN disclosed
CN-1982922-A Colored composition for color filter and color filter TOYO INK MFG CO (JP) 2007-06-20 CN disclosed
CN-1307443-C Blue colored composition for color filter and color filter TOYO INK MFG CO LTD TOPPAN PRI (JP) 2007-03-28 CN disclosed
CN-1673782-A Colored composition for color filter and color filter TOPPAN PRINTING CO LTD (JP) 2005-09-28 CN disclosed
CN-1645170-A Blue colored composition for color filter and color filter TOYO INK MFG CO LTD TOPPAN PRI (JP) 2005-07-27 CN disclosed